Equity Vesting Acceleration. Vesting acceleration (and exercisability, as applicable) as to 100% of the then-unvested shares subject to each of the Executive’s then-outstanding Company equity awards subject to only time-based (and not performance-based) vesting. In the case of equity awards with performance-based vesting, such awards will be treated as set forth in the applicable award agreement. For the avoidance of doubt, in the event of the Executive’s Qualifying Pre-CIC Termination, any unvested portion of the Executive’s then-outstanding equity awards will remain outstanding until the earlier of (x) ninety (90) days following the Qualifying Termination or (y) the occurrence of a Change in Control, solely so that any benefits due on a Qualifying Pre-CIC Termination can be provided if a Change in Control occurs within the ninety (90) day period following the Qualifying Termination (provided that in no event will the Executive’s stock options or similar equity awards remain outstanding beyond the equity award’s maximum term to expiration). If no Change in Control occurs within the ninety (90) day period following a Qualifying Termination, any unvested portion of the Executive’s equity awards automatically and permanently will be forfeited on the ninetieth (90th) day following the date of the Qualifying Termination without having vested.
Appears in 6 contracts
Samples: Employment Agreement (Acutus Medical, Inc.), Employment Agreement (Acutus Medical, Inc.), Employment Agreement (Acutus Medical, Inc.)
Equity Vesting Acceleration. Vesting acceleration (and exercisability, as applicable) as to 100% of the then-unvested shares subject to each of the Executive’s then-outstanding Company equity awards subject to only time-based (and not performance-based) vestingawards. In the case of an equity awards award with performance-based vesting, such awards will be treated as set forth unless otherwise specified in the applicable equity award agreementagreement governing such award, all performance goals and other vesting criteria will be deemed achieved at target. For the avoidance of doubt, in the event of the Executive’s Qualifying Pre-CIC TerminationTermination (as defined below), any unvested portion of the Executive’s then-outstanding equity awards will remain outstanding until the earlier of (x) ninety three (903) days months following the Qualifying Termination or (y) the occurrence of a Change in Control, solely so that any benefits due on a Qualifying Pre-CIC Termination can be provided if a Change in Control occurs within the ninety three (903) day month period following the Qualifying Termination (provided that in no event will the Executive’s stock options or similar equity awards remain outstanding beyond the equity award’s maximum term to expiration). If no Change in Control occurs within the ninety three (903) day month period following a Qualifying Termination, any unvested portion of the Executive’s equity awards automatically and permanently will be forfeited on the ninetieth three (90th3) day month anniversary following the date of the Qualifying Termination without having vested.
Appears in 4 contracts
Samples: Change in Control and Severance Agreement (Outset Medical, Inc.), Change in Control and Severance Agreement (Outset Medical, Inc.), Change in Control and Severance Agreement (Outset Medical, Inc.)
Equity Vesting Acceleration. Vesting acceleration (and exercisability, as applicable) as to 100% of the then-unvested shares subject to each of the Executive’s then-outstanding Company equity awards subject to only time-based (and not performance-based) vestingawards. In the case of an equity awards award with performance-based vesting, such awards will be treated as set forth unless otherwise specified in the applicable equity award agreementagreement governing such award, all performance goals and other vesting criteria will be deemed achieved at target. For the avoidance of doubt, in the event of the Executive’s Qualifying Pre-CIC TerminationTermination (as defined below), any unvested portion of the Executive’s then-outstanding equity awards will remain outstanding until the earlier of (x) ninety sixty (9060) days following the Qualifying Termination or (y) the occurrence of a Change in Control, solely so that any benefits due on a Qualifying Pre-CIC Termination can be provided if a Change in Control occurs within the ninety sixty (9060) day period days following the Qualifying Termination (provided that in no event will the Executive’s stock options or similar equity awards remain outstanding beyond the equity award’s maximum term to expiration). If no Change in Control occurs within the ninety sixty (9060) day period days following a Qualifying Termination, any unvested portion of the Executive’s equity awards automatically and permanently will be forfeited on the ninetieth sixtieth (90th60th) day following the date of the Qualifying Termination without having vested.
Appears in 4 contracts
Samples: Change in Control and Severance Agreement (Ra Medical Systems, Inc.), Change in Control and Severance Agreement (Ra Medical Systems, Inc.), Change in Control and Severance Agreement (Ra Medical Systems, Inc.)
Equity Vesting Acceleration. Vesting acceleration (and exercisability, as applicable) as to 100% of the then-unvested shares subject to each of the Executive’s then-outstanding Company equity awards subject to only time-based (and not performance-based) vestingawards. In the case of an equity awards award with performance-based vesting, such awards will be treated as set forth unless otherwise specified in the applicable equity award agreementagreement governing such award, all performance goals and other vesting criteria will be deemed achieved at target. For the avoidance of doubt, in the event of the Executive’s Qualifying Pre-CIC TerminationPre‑CIC Termination (as defined below), any unvested portion of the Executive’s then-outstanding equity awards will remain outstanding until the earlier of (x) ninety sixty (9060) days following the Qualifying Termination or (y) the occurrence of a Change in Control, solely so that any benefits due on a Qualifying Pre-CIC Pre‑CIC Termination can be provided if a Change in Control occurs within the ninety sixty (9060) day period days following the Qualifying Termination (provided that in no event will the Executive’s stock options or similar equity awards remain outstanding beyond the equity award’s maximum term to expiration). If no Change in Control occurs within the ninety sixty (9060) day period days following a Qualifying Termination, any unvested portion of the Executive’s equity awards automatically and permanently will be forfeited on the ninetieth sixtieth (90th60th) day following the date of the Qualifying Termination without having vested.
Appears in 4 contracts
Samples: Change in Control and Severance Agreement (Silk Road Medical Inc), Change in Control and Severance Agreement (Silk Road Medical Inc), Change in Control and Severance Agreement (Silk Road Medical Inc)
Equity Vesting Acceleration. Vesting acceleration (and exercisability, as applicable) as to 100% of the then-unvested shares subject to each of the Executive’s then-outstanding Company equity awards subject to only time-based (and not performance-based) vestingawards. In the case of an equity awards award with performance-based vesting, such awards vesting all performance goals and other vesting criteria will be treated as set forth in the applicable award agreementdeemed achieved at no less than target. For the avoidance of doubt, in the event of the Executive’s Qualifying Pre-CIC TerminationPre‑CIC Termination (as defined below), any unvested portion of the Executive’s then-outstanding equity awards will remain outstanding until the earlier of (x) ninety (90) days following the Qualifying Termination or (y) the occurrence of a Change in Control, solely so that any benefits due on a Qualifying Pre-CIC Pre‑CIC Termination can be provided if a Change in Control occurs within the ninety (90) day period days following the Qualifying Termination (provided that in no event will the Executive’s stock options or similar equity awards remain outstanding beyond the equity award’s maximum term to expiration). If no Change in Control occurs within the ninety (90) day period days following a Qualifying Termination, any unvested portion of the Executive’s equity awards automatically and permanently will be forfeited on the ninetieth sixtieth (90th60th) day following the date of the Qualifying Termination without having vested.
Appears in 2 contracts
Samples: Change in Control and Severance Agreement (Ra Medical Systems, Inc.), Change in Control and Severance Agreement (Ra Medical Systems, Inc.)
Equity Vesting Acceleration. Vesting acceleration (and exercisability, as applicable) as to 100% of the then-unvested shares subject to each of the Executive’s 's then-outstanding Company equity awards subject to only time-based (and not performance-based) vestingawards. In the case of an equity awards award with performance-based vesting, such awards will be treated as set forth unless otherwise specified in the applicable equity award agreementagreement governing such award, all performance goals and other vesting criteria will be deemed achieved at target. For the avoidance of doubt, in the event of the Executive’s 's Qualifying Pre-CIC TerminationTermination (as defined below), any unvested portion of the Executive’s 's then-outstanding equity awards will remain outstanding until the earlier of (x) ninety sixty (9060) days following the Qualifying Termination or (y) the occurrence of a Change in Control, solely so that any benefits due on a Qualifying Pre-CIC Termination can be provided if a Change in Control occurs within the ninety sixty (9060) day period days following the Qualifying Termination (provided that in no event will the Executive’s 's stock options or similar equity awards remain outstanding beyond the equity award’s 's maximum term to expiration). If no Change in Control occurs within the ninety (90sixty ( 60) day period days following a Qualifying Termination, any unvested portion of the Executive’s 's equity awards automatically and permanently will be forfeited on the ninetieth sixtieth (90th60th) day following the date of the Qualifying Termination without having vested.
Appears in 2 contracts
Samples: Change in Control and Severance Agreement (Silk Road Medical Inc), Change in Control and Severance Agreement (Silk Road Medical Inc)
Equity Vesting Acceleration. Vesting acceleration (and exercisability, as applicable) as to 100% of the then-unvested shares subject to each of the Executive’s 's then-outstanding Company equity awards subject to only time-based (and not performance-based) vestingawards. In the case of an equity awards award with performance-based vesting, such awards will be treated as set forth unless otherwise specified in the applicable equity award agreementagreement governing such award, all performance goals and other vesting criteria will be deemed achieved at target. For the avoidance of doubt, in the event of the Executive’s 's Qualifying Pre-CIC TerminationTermination (as defined below), any unvested portion of the Executive’s 's then-outstanding equity awards will remain outstanding until the earlier of (x) ninety sixty (9060) days following the Qualifying Termination or (y) the occurrence of a Change in Control, solely so that any benefits due on a Qualifying Pre-CIC Termination can be provided if a Change in Control occurs within the ninety sixty (9060) day period days following the Qualifying Termination (provided that in no event will the Executive’s 's stock options or similar equity awards remain outstanding beyond the equity award’s 's maximum term to expiration). If no Change in Control occurs within the ninety sixty (9060) day period days following a Qualifying Termination, any unvested portion of the Executive’s 's equity awards automatically and permanently will be forfeited on the ninetieth sixtieth (90th60th) day following the date of the Qualifying Termination without having vested.
Appears in 2 contracts
Samples: Change in Control and Severance Agreement (Silk Road Medical Inc), Change in Control and Severance Agreement (Silk Road Medical Inc)
Equity Vesting Acceleration. Vesting acceleration (and exercisability, as applicable) as to 100% of the then-unvested shares subject to each of the Executive’s then-outstanding Company equity awards subject to only time-based (and not performance-based) vestingawards. In the case of an equity awards award with performance-based vesting, such awards will be treated as set forth unless otherwise specified in the applicable equity award agreementagreement governing such award, all performance goals and other vesting criteria will be deemed achieved at target. For the avoidance of doubt, in the event of the Executive’s Qualifying Pre-CIC TerminationTermination (as defined below), any unvested portion of the Executive’s then-outstanding equity awards will remain outstanding until the earlier of (x) ninety sixty (9060) days following the Qualifying Termination or (y) the occurrence of a Change in Control, solely so that any benefits due on a Qualifying Pre-CIC Termination can be provided if a Change in Control occurs within the ninety sixty (9060) day period days following the Qualifying Termination (provided that in no event will the Executive’s stock options or similar equity awards remain outstanding beyond the equity award’s maximum term to expiration). If no Change in Control occurs within the ninety sixty (9060) day period days following a Qualifying Termination, any unvested portion of the Executive’s equity awards automatically and permanently will be forfeited on the ninetieth sixtieth (90th601h) day following the date of the Qualifying Termination without having vested.
Appears in 2 contracts
Samples: Change in Control and Severance Agreement (Silk Road Medical Inc), Change in Control and Severance Agreement (Silk Road Medical Inc)
Equity Vesting Acceleration. Vesting acceleration (and exercisability, as applicable) as to 100% of the then-unvested shares subject to each of the Executive’s 's then-outstanding Company equity awards subject to only time-based (and not performance-based) vestingawards. In the case of an equity awards award with performance-based vesting, such awards will be treated as set forth unless otherwise specified in the applicable equity award agreementagreement governing such award, all performance goals and other vesting criteria will be deemed achieved at target. For the avoidance of doubt, in the event of the Executive’s 's Qualifying Pre-CIC TerminationTermination (as defined below), any unvested portion of the Executive’s 's then-outstanding equity awards will remain outstanding until the earlier of (x) ninety sixty (9060) days following the Qualifying Termination or (y) the occurrence of a Change in Control, solely so that any benefits due on a Qualifying Pre-CIC Termination can be provided if a Change in Control occurs within the ninety sixty (9060) day period days following the Qualifying Termination (provided that in no event will the Executive’s 's stock options or similar equity awards remain outstanding beyond the equity award’s 's maximum term to expiration). If no Change in Control occurs within the ninety sixty (9060) day period days following a Qualifying Termination, any unvested portion of the Executive’s 's equity awards automatically and permanently will be forfeited on the ninetieth sixtieth (90th601h) day following the date of the Qualifying Termination without having vested.
Appears in 2 contracts
Samples: Change in Control and Severance Agreement (Silk Road Medical Inc), Change in Control and Severance Agreement (Silk Road Medical Inc)
Equity Vesting Acceleration. Vesting acceleration (and exercisability, as applicable) as to 100% of the then-unvested shares subject to each of the Executive’s then-outstanding Company equity awards subject to only time-based (and not performance-based) vestingawards. In the case of an equity awards award with performance-based vesting, unless the applicable equity award agreement governing such awards award provides for more favorable treatment, all performance goals and other vesting criteria will be treated as set forth in the applicable award agreementdeemed achieved at target. For the avoidance of doubt, in the event of the Executive’s Qualifying Pre-CIC TerminationPre‑CIC Termination (as defined below), any unvested portion of the Executive’s then-outstanding equity awards will remain outstanding until the earlier of (x) ninety three (903) days months following the Qualifying Termination or (y) the occurrence of a Change in Control, solely so that any benefits due on a Qualifying Pre-CIC Pre‑CIC Termination can be provided if a Change in Control occurs within the ninety three (903) day month period following the Qualifying Termination (provided that in no event will the Executive’s stock options or similar equity awards remain outstanding beyond the equity award’s maximum term to expiration). If no Change in Control occurs within the ninety three (903) day month period following a Qualifying Termination, any unvested portion of the Executive’s equity awards automatically and permanently will be forfeited on the ninetieth three (90th3) day month anniversary following the date of the Qualifying Termination without having vested.
Appears in 2 contracts
Samples: Change in Control and Severance Agreement (Outset Medical, Inc.), Change in Control and Severance Agreement (Outset Medical, Inc.)
Equity Vesting Acceleration. Vesting acceleration (and exercisability, as applicable) as to 100% of the then-unvested shares subject to each of the Executive’s then-outstanding Company equity awards subject to only time-based (and not performance-based) vestingawards. In the case of an equity awards award with performance-based vesting, such awards will be treated as set forth unless otherwise specified in the applicable equity award agreementagreement governing such award, all performance goals and other vesting criteria will be deemed achieved at target. For the avoidance of doubt, in the event of the Executive’s Qualifying Pre-CIC TerminationTermination (as defined below), any unvested portion of the Executive’s then-outstanding equity awards will remain outstanding until the earlier of (x) ninety sixty (9060) days following the Qualifying Termination or (y) the occurrence of a Change in Control, solely so that any benefits due on a Qualifying Pre-CIC Termination can be provided if a Change in Control occurs within the ninety sixty (9060) day period days following the Qualifying Termination (provided that in no event will the Executive’s stock options or similar equity awards remain outstanding beyond the equity award’s maximum term to expiration). If no Change in Control occurs within the ninety sixty (9060) day period days following a Qualifying Termination, any unvested portion - 2 - of the Executive’s equity awards automatically and permanently will be forfeited on the ninetieth sixtieth (90th60th) day following the date of the Qualifying Termination without having vested.
Appears in 1 contract
Samples: Change in Control and Severance Agreement (Silk Road Medical Inc)
Equity Vesting Acceleration. Vesting acceleration (and exercisability, as applicable) as to 100% of the then-unvested shares subject to each of the Executive’s then-outstanding Company equity awards subject to only time-based (and not #93411817v3 performance-based) vesting. In the case of equity awards with performance-based vesting, such awards will be treated as set forth in the applicable award agreement. For the avoidance of doubt, in the event of the Executive’s Qualifying Pre-CIC Termination, any unvested portion of the Executive’s then-outstanding equity awards will remain outstanding until the earlier of (x) ninety (90) days following the Qualifying Termination or (y) the occurrence of a Change in Control, solely so that any benefits due on a Qualifying Pre-CIC Termination can be provided if a Change in Control occurs within the ninety (90) day period following the Qualifying Termination (provided that in no event will the Executive’s stock options or similar equity awards remain outstanding beyond the equity award’s maximum term to expiration). If no Change in Control occurs within the ninety (90) day period following a Qualifying Termination, any unvested portion of the Executive’s equity awards automatically and permanently will be forfeited on the ninetieth (90th) day following the date of the Qualifying Termination without having vested.
Appears in 1 contract
Equity Vesting Acceleration. Vesting acceleration (and exercisability, as applicable) as to 100% of the then-unvested shares subject to each of the Executive’s then-outstanding Company equity awards subject to only time-based (and not performance-based) vestingawards. In the case of an equity awards award with performance-based vesting, such awards will be treated as set forth unless otherwise specified in the applicable equity award agreementagreement governing such award, all performance goals and other vesting criteria will be deemed achieved at target. For the avoidance of doubt, in the event of the Executive’s Qualifying Pre-CIC TerminationTermination (as defined below), any unvested portion of the Executive’s then-outstanding equity awards will remain outstanding until the earlier of (x) ninety sixty (9060) days following the Qualifying Termination or (y) the occurrence of a Change in Control, solely so that any benefits due on a Qualifying Pre-CIC Termination can be provided if a Change in Control occurs within the ninety sixty (9060) day period days following the Qualifying Termination (provided that in no event will the Executive’s stock options or similar equity awards remain outstanding beyond the equity award’s maximum term to expiration). If no Change in Control occurs within the ninety sixty (9060) day period days following a Qualifying Termination, any unvested portion of the Executive’s equity awards automatically and permanently will be forfeited on the ninetieth sixtieth (90th60th) day following the date of the Qualifying Termination without having vested..
Appears in 1 contract
Samples: Change in Control and Severance Agreement (Silk Road Medical Inc)
Equity Vesting Acceleration. Vesting acceleration (and exercisability, as applicable) as to 100% of the then-unvested shares subject to each of the Executive’s then-outstanding Company equity awards subject to only time-based (and not performance-based) vestingawards. In the case of an equity awards award with performance-based vesting, such awards will be treated as set forth unless otherwise specified in the applicable equity award agreementagreement governing such award, all performance goals and other vesting criteria will be deemed achieved at 100% of target levels. For the avoidance of doubt, in the event of the Executive’s Qualifying Pre-CIC TerminationTermination (as defined below), any unvested portion of the Executive’s then-outstanding equity awards will remain outstanding until the earlier of (x) ninety three (903) days months following the Qualifying Termination or (y) the occurrence of a Change in Control, solely so that any benefits due on a Qualifying Pre-CIC Termination can be provided if a Change in Control occurs within the ninety three (903) day period months following the Qualifying Termination (provided that in no event will the Executive’s stock options or similar equity awards remain outstanding beyond the equity award’s maximum term to expiration). If no Change in Control occurs within the ninety three (903) day period months following a Qualifying Termination, any unvested portion of the Executive’s equity awards automatically and permanently will be forfeited on the ninetieth three (90th3) day following month anniversary of the date of the Qualifying Termination without having vested.
Appears in 1 contract
Samples: Change in Control and Severance Agreement (Oyster Point Pharma, Inc.)
Equity Vesting Acceleration. Vesting acceleration (and exercisability, as applicable) as to 100% of the then-unvested shares subject to each of the Executive’s then-outstanding Company equity awards subject to only time-based (and not performance-based) vesting. In the case of equity awards with performance-based vesting, such awards will be treated as set forth in the applicable award agreement. For the avoidance of doubt, in the event of the Executive’s Qualifying Pre-CIC Pre‑CIC Termination, any unvested portion of the Executive’s then-outstanding equity awards will remain outstanding until the earlier of (x) ninety (90) days following the Qualifying Termination or (y) the occurrence of a Change in Control, solely so that any benefits due on a Qualifying Pre-CIC Pre‑CIC Termination can be provided if a Change in Control occurs within the ninety (90) day period following the Qualifying Termination (provided that in no event will the Executive’s stock options or similar equity awards remain outstanding beyond the equity award’s maximum term to expiration). If no Change in Control occurs within the ninety (90) day period following a Qualifying Termination, any unvested portion of the Executive’s equity awards automatically and permanently will be forfeited on the ninetieth (90th) day following the date of the Qualifying Termination without having vested.
Appears in 1 contract